Want to track ABT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Abbott Laboratories (ABT) Statistics
Valuation metrics
Market Cap -
Enterprise value 199.85B
Trailing P/E (ttm) 32.03
Forward P/E -
PEG ratio -0.52
Price/Sales (ttm) 3.7
Price/Book (mrq) 3.4
Enterprise Value/Revenue 4.29
Enterprise Value/EBITDA 17.65
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1
Average volume (90 days) -
Price summary
52-Week low 65
52-Week high 102
Beta -
50-Day moving average 86.17
200-Day moving average 79.29
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 2.48
Trailing annual dividend yield 0.0249%
5-Year annual dividend yield -
Payout ratio 0.79
Dividend Date 17 Aug 2026
Ex-Dividend Date 15 Jul 2026
Last split factor 2:1
Last split Date 3 Jan 2013
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.12%
Operating margin 0.17%
Operational effectiveness
Return on assets 0.05%
Return on equity 0.11%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 26.73
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 3.11
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.21
Total debt (mrq) -
Total Debt/Equity (mrq) 0.64
Current ratio (mrq) 1.38%
Book value per share (mrq) 29.7
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
